In addition to the promising results shown with MCT1 inhibition, we hypothesize that the function of MCT4 is also of great importance for pH regulation and growth in the context of in vivo metabolism when tumour cells are exposed to a hypoxic microenvironment, and therefore therapies targeting MCT4 specifically should also be explored. The gene discussed is SLC16A1; the disease is neoplasm.